Dr Ashish Dwivedi graduated from CSIR-Indian Institute of Toxicology Research, Lucknow, India, in Phototoxicology. Thereafter, he enriched himself in the same domain of research as Post-Doctoral Fellow at Israel Institute of Technology, Israel, Colorado University, USA, and Banaras Hindu University, Varanasi, India. Based on his outstanding research experience, he got an opportunity to return to his parenteral research organization-CSIR-IITR, where he is currently a Scientist in the Drug & Chemical Toxicology Group. In a decade-long research career, Dr Dwivedi has established himself as one of the pioneers in the area of phototoxicity/photo safety with special reference to the phot-safety of cosmetics ingredients (hair dyes, colorants, preservatives and fragrances), therapeutic agents, nanotized phytochemicals, environmental pollutants, etc. Besides the laboratory work, he has also been involved in fostering contemporary science to Post-Graduate, PhD students, researchers, and university teachers. Dr Dwivedi’s research efforts have been rewarding in terms of the quantifiable number of research publications in journals of high repute. He has also edited three books for Springer Nature in the area of Photo protection, Skin Aging, and Cosmetics safety and alternative models. He is a member of various scientific societies, including the society of Toxicology, USA, Indian Photobiology Society, India, Society of Toxicology, India, etc.
Professor AB Pant is a seasoned toxicologist with over thirty years of active research career. Presently serving as ‘Senior Principal Scientist at CSIR-Indian Institute of Toxicology Research, Lucknow, and also a ‘Professor’ of the Academy of Scientific & Innovative Research, an Institution of National Importance set up by the Act of Parliament, Government of India. In the scientific fraternity, Professor Pant is renowned for his elegant research on the application of human stem cells and iPSCs in developmental neurotoxicity and for establishing the number of in vitro model systems as an alternative to laboratory animals for biomedical research. He also founded a new discipline of "In-Vitro Toxicology" in the country. He also dedicated himself to fostering contemporary science to Post-Graduate, PhD students, researchers, and university teachers. He is a lead GLP inspector for the Government of India and also serves as an expert for regulatory bodies, such as BIS, CDSCO, NABL, FSSAI, NGCMA, ICMR, DST, Pharmacovigilance, etc. He has won several awards and honours, including Vigyan Ratna Award-2010 (CST UP); Shakuntala Amir Chand Prize-2007 (ICMR); National Bioscience Award-2012 (DBT); Prof. KT Shetty Memorial Oration Award-2017 (Indian Academy of Neurosciences), Toxicology Promotion Award-2018 (National Academy of Sciences, Allahabad), STOX/ASAW Gold Medal (STOX, India), etc. He has been elected Fellow of the Academy of Toxicological Sciences, USA, Society of Toxicology, India, Indian Academy of Neurosciences, Academy of Sciences for Animal Welfare, India, Academy of Environmental Biology India, etc. In view of outstanding credibility in toxicology, Professor Pant has been included as a global toxicologist in the ‘European and United Kingdom Register of Toxicologists and has also been conferred the DSc (h. c.) degree by HNB Medical Education University, Dehradun, Uttarakhand, India. He currently serves as Chairman and Member of several National and International Committees/ Boards of Government Institutes and Bodies. He also serves as a member of the editorial board of several reputable journals.
Dr Shiv Poojan, Founder & CEO of bioTox Solutions, is a visionary entrepreneur and academician with over 15 years of experience in scientific research. Prior to BioTox, Dr. Shiv held prestigious positions at research institutions worldwide as the Head of R&D at MS Clinical Research Pvt. Ltd, Bangalore (2022-23, as a Scientist at Eliksa Therapeutics, Philadelphia, USA (2021-22), Research Scientist at the Sidney Kimmel Cancer Center, Thomas Jefferson University in USA (2018-2021), and Post Doctoral Fellow at the National Cancer Center in South Korea (2014-2018). He has received his PhD (Biochemistry) from CSIR-Indian Institute of Toxicology Research, India. He is a leading expert in media formulation and tissue culture, extending the lifespan of 3D cell cultures and ex-plant growth beyond two weeks – a groundbreaking achievement. Dr. Shiv's expertise extends to drug discovery and development. He has experience in preclinical assessments, developing knock-in/knock-out transgenic mice for cancer research, and creating cell lines for drug testing. His research has been recognized with awards like the Rambhau Kulkerny Best Young Scientist Award from ICAR and the prestigious Carl Storm International Diversity Fellowship. Notably, he was the first in India to establish natural human
